Chief Executive Officer
Kamran Tahamtanzadeh, B.A.
is an accomplished healthcare executive with over 25 years of global leadership experience in precision medicine, diagnostics, and digital health. As CEO, he brings a strong track record of scaling companies, securing strategic partnerships and funding, and commercializing innovative technologies across genomics, epigenetics, and cell therapy.
Chief Science Officer
Darya Orlova, PhD
is an accomplished scientific leader with deep expertise in computational biology, immunology, and biophysics. As Chief Science Officer, she brings over 15 years of experience advancing drug target and biomarker discovery through systems biology, machine learning, and mechanistic modeling, with prior leadership roles at Genentech, Cell Signaling Technology, and Stanford University.